KRAS and non-small cell lung carcinoma: A spatial TME analysis of Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant NSCLC patients undergoing ICI therapy revealed that infiltration of CD68+ macrophages and PanCK+/CD33+/FOXP3+ cells is associated with resistance to ICI (76).